65,437 trials
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome · Adult Acute Megakaryoblastic Leukemia (M7) · Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Primary: Disease-free Survival-incidence of Survival Without Relapse — 47 percentage of participants
Infections, Streptococcal
Primary: Antibody Concentrations Against Pneumococcal Serotypes (Epoch 001) — 2.78; 3.03; 4.23; 3.87 µg/mL
Acellular Pertussis · Tetanus · Diphtheria
Primary: Number of Subjects With Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibodies — 427; 405; 425; 412 Participants
Hand Dermatosis
Primary: Investigator Global Assessment — 1.0; 1.1 units on a scale
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities · Adult Acute Myeloid Leukemia With Del(5q) · Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Primary: Evaluate the Risk of Transplant Related Mortality. — 20 percentage of participants
Hernia Repair With Compartment Syndrome
Primary: Hernia Recurrence — 11; 12 percentage of patients
Glabellar Frown Lines
Primary: Efficacy, Measured as the Percentage of Participants Who Responded to Treatment — 95.7; 99.2 percentage of participants
Sinusitis · Nasal Polyps
Primary: SNOT-22 Scores — 31.5; 10.29; 15.88 units on a scale
Atrial Fibrillation · Deep Vein Thrombosis · Dilated Cardiomyopathies
Primary: Improved Warfarin Adherence/% Timeout of Target INR Range — 31.6; 23.8; 30.1; 23.9 percentage of out of target INR range
Primary Immunodeficiency Diseases
Primary: Number of Serious Bacterial Infections Per Person-year of Treatment — 0.080 Serious infections per person-year of tr
Partially Edentulous Jaw
Primary: Change in Millimeters of Bone Loss Surrounding the Implant Device — -0.35; -0.82 millimeters
Growth and Development
Primary: Fractional Iron Absorption — 2.08; 1.25 % Iron Absorbed — p=0.0944
Asthma · Wheezing
Primary: Differential Response to the Three Therapies Based on Fixed Threshold Criteria for the Following Asthma Control Measures: Use of Oral Prednisone for Acute Asthma…
Healthy
Primary: Maximum Observed Plasma Concentration (Cmax) of S-ibuprofen — 13268.7; 14967.2 nanogram (ng)/ millilitre (mL)
Intraocular Melanoma · Melanoma (Skin)
Primary: Number of Patients Evulated for Toxicity and Safety — 17; 17 participants